MicroBiome Biological Life Product
Anticancer Mechanism of MBLP
Pathway 01
Radiotherapy Combination
bcl-2 inhibition · ROS amplification · Caspase cascade · Radiosensitization
→ Explore pathway
Pathway 02
Chemotherapy Synergy
Gut–Tumor Axis · Drug sensitivity ↑ · SCFA production · Chemoresistance overcome
→ Explore pathway
Pathway 03
ICI / Immunotherapy
PD-L1↓ · CD8⁺ T Cell & NK · TME remodeling · Treg suppression · IFN-γ↑
→ Explore pathway
Convergence Outcome
✦ Synergistic Anticancer Effect
Three independent pathways converge → Maximized Tumor Killing · Resistance Overcome · Minimized Side Effects
↑ Tumor Killing
↓ Drug Resistance
↓ Side Effects
Gut–Tumor Axis
TME Remodeling
Immune Reprogramming
Pathway 01
Radiotherapy Combination · Radiosensitization
MBLPMicroBiome Bio Life Product
☢ Radiation
bcl-2 InhibitionAnti-apoptotic ↓
DNA Damage
ROS ↑MBLP Enhanced
Gut MicrobiomeDiversity Restored
ApoptosisProgrammed Cell Death
Caspase-9
Caspase-3/7
Tumor Cell Death↑ Radiosensitivity
Enhanced Tumor Killing via Radiation + MBLP
Pathway 02
Chemotherapy Synergy · Gut–Tumor Axis
MBLPMicroBiome Bio Life Product
[Rx]Chemo Drug
Gut MicrobiomeDrug Metabolism Opt.
Drug Sensitivity ↑Uptake ↑
Gut Barrier ProtectionChemo Toxicity ↓
SCFA ProductionShort-Chain Fatty Acids
Anti-inflammatoryCytokine Regulation
Drug Resistance Overcome
Optimized Drug Efficacy via MBLP + Chemo↑ Survival · ↓ Side Effects
Pathway 03
Immunotherapy (ICI) Synergy
MBLPMicroBiome Bio Life Product
[ICI]Anti-PD-1
Gut MicrobiomeImmune Modulation
PD-L1 Expression ↓Downregulation
T Cell ActivationCD8⁺ · TIL ↑
NK Cell Activation
TME RemodelingTumor Microenvironment
Treg SuppressionImmunosuppr. ↓
IFN-γ · IL-12 ↑Pro-inflammatory Cytokines
Amplified Anti-tumor Immunity via MBLP + ICIImmunotherapy Synergy · ↑ Anti-tumor Immunity